Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Evelyne, Kohli"'
Publikováno v:
Vaccines, vol. 9, no. 8, pp. 883
Vaccines
Vaccines, Vol 9, Iss 883, p 883 (2021)
Vaccines
Vaccines, Vol 9, Iss 883, p 883 (2021)
Patients with rheumatoid arthritis (RA) are treated with drugs that may impact their immune responses to SARS-CoV-2 vaccines. We describe here the anti-Spike (anti-S) IgG and neutralizing antibody responses induced by the mRNA-1273 SARS-CoV-2 vaccine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43590811d1010b516fd7d5e27e0bf90b
https://serval.unil.ch/notice/serval:BIB_1C0CC61D746E
https://serval.unil.ch/notice/serval:BIB_1C0CC61D746E
Autor:
Killian Chaumonnot, Sophie Masson, Hugo Sikner, Alexanne Bouchard, Valentin Baverel, Pierre-Simon Bellaye, Bertrand Collin, Carmen Garrido, Evelyne Kohli
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 12, Iss 1, Pp 1-15 (2021)
Cell Death and Disease, Vol 12, Iss 1, Pp 1-15 (2021)
The role of GRP94, an endoplasmic reticulum (ER) stress protein with both pro- and anti-inflammatory functions, has not been investigated in macrophages during ER stress, whereas ER stress has been reported in many diseases involving macrophages. In
Publikováno v:
Vaccines, vol. 9, no. 10, pp. 1140
Vaccines
Vaccines, Vol 9, Iss 1140, p 1140 (2021)
Vaccines
Vaccines, Vol 9, Iss 1140, p 1140 (2021)
Patients with multiple sclerosis (MS) are treated with drugs that may impact immune responses to SARS-CoV-2 vaccination. Evaluation of “prime-boost” (heterologous) vaccination regimens including a first administration of a viral vector-based vacc
Autor:
Arlette Hammann, Eric Solary, Oleg N. Demidov, Gaëtan Jego, Robinet E, A. Seignez, Sarah Richaud, Anastasia R. Goloudina, Evelyne Kohli, Magali Svrcek, Carmen Garrido, Eric Fourmaux, Deepti A, Anne-Laure Joly, Sophie Hébrard, Ada Collura, Elise Schmitt
Publikováno v:
Oncogene
Oncogene, 2016, 35 (22), pp.2842-2851. ⟨10.1038/onc.2015.242⟩
Oncogene, Nature Publishing Group, 2016, 35 (22), pp.2842-2851. ⟨10.1038/onc.2015.242⟩
Oncogene, Nature Publishing Group, 2016, 35 (22), pp.2842-2851. 〈http://www.nature.com/onc/journal/v35/n22/full/onc2015242a.html〉. 〈10.1038/onc.2015.242〉
Oncogene, 2016, 35 (22), pp.2842-2851. ⟨10.1038/onc.2015.242⟩
Oncogene, Nature Publishing Group, 2016, 35 (22), pp.2842-2851. ⟨10.1038/onc.2015.242⟩
Oncogene, Nature Publishing Group, 2016, 35 (22), pp.2842-2851. 〈http://www.nature.com/onc/journal/v35/n22/full/onc2015242a.html〉. 〈10.1038/onc.2015.242〉
IF 7.932; International audience; Graft versus host disease (GvHD), which is the primary complication of allogeneic bone marrow transplantation, can alter the intestinal barrier targeted by activated donor T-cells. Chemical inhibition of the stress p
Autor:
Didier Poncet, Fatou Thiam, John D. Clements, Cyrille Di Martino, Claire Cachia, Evelyne Kohli, Fabienne Bon, Annie Charpilienne, Christelle Basset
Publikováno v:
Toxins
Toxins, Vol 2, Iss 8, Pp 2007-2027 (2010)
Volume 2
Issue 8
Pages 2007-2027
Toxins, Vol 2, Iss 8, Pp 2007-2027 (2010)
Volume 2
Issue 8
Pages 2007-2027
LT-R192G, a mutant of the thermolabile enterotoxin of E. coli, is a potent adjuvant of immunization. Immune responses are generally analyzed at the end of protocols including at least 2 administrations, but rarely after a prime. To investigate this p
Autor:
Jean Cohen, Annie Charpilienne, Manuel A. Franco, Agathe Ogier, Pierre Pothier, Evelyne Kohli
Publikováno v:
European Journal of Immunology
European Journal of Immunology, Wiley-VCH Verlag, 2005, 35 (7), pp.2122-2130. ⟨10.1002/eji.200526059⟩
European Journal of Immunology, Wiley-VCH Verlag, 2005, 35 (7), pp.2122-2130. ⟨10.1002/eji.200526059⟩
International audience; Virus-like particles containing the rotavirus (RV) internal proteins VP2 and VP6 (2/6-VLP) have been shown to induce serum and fecal antibodies as well as protection in mice after intranasal administration with a mutant of E.
Autor:
Lionel Piroth, Marielle Buisson, Catherine Quantin, Michel Duong, Henri Portier, Christine Binquet, Pascal Chavanet, Evelyne Kohli, Michal Abrahamowicz, Michèle Grappin
Publikováno v:
European Journal of Epidemiology. 19:597-604
To assess the clinical, immunological and virological evolution in HIV-1 infected patients with CD4 T-cell count above 500/mm3, a historical cohort of 202 untreated and 96 patients treated with HAART was longitudinally studied (median follow-up 36 mo
Autor:
Harry B. Greenberg, Maria C. Jaimes, Isabela Cajiao, Olga Lucía Rojas, Evelyne Kohli, Eugene C. Butcher, Pierre Pothier, Manuel A. Franco, Ana María González, Juana Angel, Jean Cohen
Publikováno v:
Virology
Virology, Elsevier, 2003, 305 (1), pp.93-105. ⟨10.1006/viro.2002.1708⟩
Virology, Elsevier, 2003, 305 (1), pp.93-105. ⟨10.1006/viro.2002.1708⟩
Referred to by: Corrigendum to “Rotavirus-specific B cells induced by recent infection in adults and children predominantly express the intestinal homing receptor α4β7” [Virology 305 (2003) 93–105] Virology, Volume 322, Issue 2, 1 May 2004, P
Publikováno v:
Vaccine. 17:2983-2990
The amino acid (aa) sequence 190-289 of the RSV fusion (F) glycoprotein expressed in insect cells (bF(190-289)) has been shown to partially protect BALB/c mice and to prime for a Th2 cell response. We evaluated the effects of IL-12 treatment during a
Autor:
Félix A. Rey, Evelyne Kohli, Annie Charpilienne, Patrice Vachette, Jean Cohen, I. Petitpas, Pierre Pothier, Magali Mathieu, Jean Lepault
Publikováno v:
Journal of Virology. 72:7615-7619
As a first step to gain insight into the structure of the rotavirus virion at atomic resolution, we report here the expression, purification, and crystallization of recombinant rotavirus protein VP6. This protein has the property of polymerizing in t